The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,960,768 in first-year total cost, median $1,024,654.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BBBP-V (55)]9
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY2
- BRIGHAM AND WOMEN'S HOSPITAL1
- COGNITION THERAPEUTICS, INC.1
- EMORY UNIVERSITY1
- NEUROGENETIC PHARMACEUTICALS, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Exercise and Intensive Vascular Risk Reduction in Preventing Dementia1R01AG049749-01A1 | BINDER, ELLEN FBURNS, JEFFREY MURRAYCULLUM, COLIN MUNROKELLER, JEFFREY NEILKERWIN, DIANA RZHANG, RONG | UT SOUTHWESTERN MEDICAL CENTER, TX | $3,082,775 | ZRG1 |
| 2016 | Phase 1 safety trial for CT1812, a novel small molecule therapeutic targeting a synaptic receptor for Abeta oligomers1RF1AG051593-01 | CATALANO, SUSAN M | COGNITION THERAPEUTICS, INC., PA | $2,410,669 | ZRG1 |
| 2016 | Pilot trial of dronabinol adjunctive treatment of agitation in Alzheimer's disease (AD)1R01AG050515-01A1 | FORESTER, BRENT PETERROSENBERG, PAUL B | JOHNS HOPKINS UNIVERSITY, MD | $1,024,654 | ZRG1 |
| 2016 | A biomarker-driven trial of angiotensin receptor blockers for prodromal Alzheimer1R01AG049752-01A1 | HAJJAR, IHAB M | EMORY UNIVERSITY, GA | $752,394 | ZRG1 |
| 2016 | Estimating Long-Term Disease Trajectories from Short-Term Data1R01AG049750-01A1 | DONOHUE, MICHAEL C | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $407,828 | ZRG1 |
| 2015 | Impact of Disclosing Amyloid Imaging Results to Cognitively Normal Individuals1RF1AG047866-01A1 | GREEN, ROBERT C.KARLAWISH, JASON H | BRIGHAM AND WOMEN'S HOSPITAL, MA | $4,646,052 | ZRG1 |
| 2015 | Phase 1 clinical studies with the gamma-secretase modulator, NGP 555 to establish safety, pharmacokinetics, and biomarker efficacy1R01AG049702-01 | COMER, WILLIAM TKOUNNAS, MARIA ZOE | NEUROGENETIC PHARMACEUTICALS, INC., CA | $1,379,813 | ZRG1 |
| 2015 | Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials1R01AG048252-01A1 | BREWER, JAMES BOLICHNEY, JOHN M | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $893,896 | ZRG1 |
| 2015 | Actigraphic assessment of sleep quality in the A4 trial1R01AG049872-01 | ROSENBERG, PAUL BSPIRA, ADAM PETER | JOHNS HOPKINS UNIVERSITY, MD | $362,687 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.